Marathon Fusion Publishes New Pathway for Scalable Production of Promising Cancer-Treatment Isotope Terbium-149

Terbium-149Positive

AI Analysis

Summary

Marathon Fusion announced a novel production pathway for Terbium-149, a cancer-treatment isotope, using a gadolinium precursor to overcome supply bottlenecks and enable manufacturing on widely available medical cyclotrons.

Importance:4/10

Sentiment:

0.60

isotope productiononcologymanufacturingsupply chainmedical cyclotronradiopharmaceutical

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on September 24, 2026 10:13 AM

Read Original